1992
DOI: 10.1016/0003-2697(92)90217-u
|View full text |Cite
|
Sign up to set email alerts
|

Using microparticle labeling and counting for attomole-level detection in heterogeneous immunoassay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
21
0

Year Published

1999
1999
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(21 citation statements)
references
References 13 publications
0
21
0
Order By: Relevance
“…Plasma NO 2 Ϫ plus NO 3 Ϫ (NO X ) was measured by using an NO detector-HPLC system (ENO10; Eicom, Kyoto, Japan), as described (40). Plasma cGMP concentration was determined by specific RIA (RPN226, Amersham Pharmacia) (41).…”
mentioning
confidence: 99%
“…Plasma NO 2 Ϫ plus NO 3 Ϫ (NO X ) was measured by using an NO detector-HPLC system (ENO10; Eicom, Kyoto, Japan), as described (40). Plasma cGMP concentration was determined by specific RIA (RPN226, Amersham Pharmacia) (41).…”
mentioning
confidence: 99%
“…Detection in these "biosensors" requires direct differential labeling of multiple antigens (multiplexing), which renders the use of enzyme labels difficult. Radioimmunoassays (RIAs) 2 give direct and generally sensitive results, but have important disadvantages-in addition to the lack of extensive multiplexing capabilities, there is a trend away from using radioisotopes because of ecological, safety, and economic constraints. Therefore, efforts have been made to establish direct-detection immunoassays exhibiting high sensitivity.…”
mentioning
confidence: 99%
“…One of these direct, highly sensitive immunoassays uses microparticle labeling methodology with visual counting of labeled antigen (2). Although this methodology is very sensitive (the limit of detection for human ␣-fetoprotein is 1.9 ϫ 10 7 molecules/ml), the detection process is time-consuming and cumbersome.…”
mentioning
confidence: 99%
“…These microbeads bearing rat anti-mouse IgG1 monoclonal antibody (mAb) (Pharmingen, San Diego, CA, USA), covalently coupled to the bead by the carbodiimide method [6] (control beads), were used for control experiments. Identically prepared beads were then incubated with anti-human CD18 mAb (isotype: mouse IgG1; Endogen, Woburn, MA, USA), and these (denoted anti-CD18 beads) were used for test experiments.…”
Section: Bead Preparationmentioning
confidence: 99%